Active Ingredient History

  • Now
Terbogrel (INN) is an experimental drug that has been studied for its potential to prevent the vasoconstricting and platelet-aggregating action of thromboxanes. Terbogrel is an orally available thromboxane A2 receptor antagonist and a thromboxane A synthase inhibitor. The drug was developed by Boehringer Ingelheim.   Wikipedia

  • SMILES: CC(C)(C)\N=C(/NC#N)\Nc1cccc(c1)\C(=C/CCCC(=O)O)\c2cccnc2
  • Mol. Mass: 405.5
  • ALogP: 4.41
  • ChEMBL Molecule:
More Chemistry
(5e)-6-(m-(3-tert-butyl-2-cyanoguanidino)phenyl)-6-(3-pyridyl)-5-hexenoic acid | 6-(3-(((cyanoamino)((1,1-dimethylethyl)amino)methylene)amino)phenyl)-6-(3-pyridinyl)hexenoic acid | bibv 308 | bibv-308-se | terbogrel


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue